Human drug approved for dog skin infections

FDA gives go-ahead to antibiotic for use in treating 'hot spots'

Slideshow

Image: To match FEATURE KAZAKHSTAN-EAGLES/

Animal Tracks
Find a hawk-eyed hunter, a snow-covered pup, a hungry chimp, a merry pair of ring-tailed lemurs — plus more images of cute critters.

more photos

Pet health videos

TODAY

From bow to wow: Pound pups' makeovers
Dec. 2: NBC’s Jill Rappaport shows off shelter dogs who have been given makeovers. Richard Gentles, of New York City’s Animal Care and Control, talks about ways to adopt these precious pups.

Hidden dangers for overweight pets

Abandoned pups, kittens feel recession

Miracle pup survives 3 months in wilderness

Pet turkey needs cataract surgery

updated 2:30 p.m. ET Sept. 8, 2004

WASHINGTON - The Food and Drug Administration approved using an antibiotic originally designed for humans to help treat skin infections suffered by dogs.

Simplicef was developed by Pharmacia & Upjohn Co., a division of Pfizer. Dogs ingest a single film-coated tablet once per day to treat wound infections caused by several types of bacteria including Escherichia coli, Pasteurella multocida and Staphylococcus aureus.

Infected dogs break out in rashes that redden, swell and roughen the dog’s skin. As infection worsens, “hot spots” can deepen, ooze and cause the dog’s hair to fall out.

Story continues below ↓

advertisement | your ad here

It is common for veterinarians to turn to antimicrobials approved for humans when dogs suffer similar skin infections. The FDA approval provides guidance on how much drug can safely be given to the canines once Simplicef is available to veterinarians this fall.